Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas

Fig. 3

TOX expression predicts better survival in glioma patients. Kaplan–Meier analysis of overall survival (OS), disease specific survival (DSS) and progressive free survival (PFS) based on high vs low expression of TOX in pan-glioma analysis, LGG alone, and GBM alone in the TCGA dataset. The median value of TOX expression was used as the cut-off value. P-values were obtained from the log-rank test

Back to article page